| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/30/2008 | CN101112425A Chinese traditional medicine for treating childrení»s mumps |
| 01/30/2008 | CN101112417A Rheum defervescence liniment and method for preparing the same |
| 01/30/2008 | CN101112409A Preparation of phenolic acid valid target in dandelion and use thereof for inhibiting influenza virus |
| 01/30/2008 | CN101112408A Sustained-release ji chrysanthemum tablet and method for preparing the same |
| 01/30/2008 | CN101112404A Chinese traditional medicine for treating condyloma acuminata |
| 01/30/2008 | CN101112397A Viable prebiotics bacteria microcapsule preparations for livestock and method for preparing the same |
| 01/30/2008 | CN101112389A Externally used antifungal drug for treating skin fester infection |
| 01/30/2008 | CN101112379A Azithromycin orally disintegrating tablets and method for preparing the same |
| 01/30/2008 | CN101112377A Medicinal composition for treating avian mixed infection and method for preparing the same |
| 01/30/2008 | CN101112360A Allicin fatty milk injection and preparation technics thereof |
| 01/30/2008 | CN100365123C SiRNA sequence directing towards influenza B virus membrane protein gene and its application |
| 01/30/2008 | CN100365122C SiRNA sequence directing towards influenza B virus polymerase gene and its application |
| 01/30/2008 | CN100365121C SiRNA sequence directing towards influenza B virus nucleocapsid gene and its application |
| 01/30/2008 | CN100365020C Protein from snake venom for preventing and treating pyemia |
| 01/30/2008 | CN100365018C Antibiotic peptides and their prepn process and application |
| 01/30/2008 | CN100365009C Anti HBV infection and hepatitis B-preventing nucleotide sequence and its use |
| 01/30/2008 | CN100364980C Preparation method of imidazole aromatic alcohol analog derivative with optical activity |
| 01/30/2008 | CN100364975C Medication for anti virus of respiratory tract and application |
| 01/30/2008 | CN100364605C Specific pellet for treating cold, and preparation method |
| 01/30/2008 | CN100364599C Oil of aromatic turmeric dripping pills and its preparing process |
| 01/30/2008 | CN100364591C External-application medicine for treating icterus of liver disease |
| 01/30/2008 | CN100364573C Chinese medicine for treating hepatitis B |
| 01/30/2008 | CN100364571C Chinese medicine preparation for anti-virus and its preparing method |
| 01/30/2008 | CN100364544C Gelatin micro-particles carried with dichloromethylene diphosphonate, and its prepn. method |
| 01/30/2008 | CN100364540C Pharmaceutical use of (2s-cis)-(+)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepine-4(5H)-one for treating hepatitis |
| 01/30/2008 | CN100364534C Use of n-substituted-1,5-di deoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 01/30/2008 | CN100364527C Composition of vitamin C and arginine and its application |
| 01/30/2008 | CN100364520C Tebinaifen hydrochloride suppository and its preparation method |
| 01/30/2008 | CN100364449C Health-care tea infusion granule |
| 01/29/2008 | USRE40040 by stereoselective displacement by a nitrogenous nucleophilic compound of the activated alcohol functional group present at this 4'' position in a corresponding derivative |
| 01/29/2008 | US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of |
| 01/29/2008 | US7323563 Hydroxamic acid derivatives as antibacterials |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323471 Administering azathioprine, 6-mercaptopurine, or 6-thioguanine nucleotide, or their salts for treating graft-versus-host disease of the mouth; oral rinse |
| 01/29/2008 | US7323470 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323460 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | US7323453 Administering substituted (beta -D-ribofuranosyl)purines or (beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidines alone or incombination with cidofovir, ribavirin, levovirin, or viramidine, particularly against vaccinia virus or variola virus infections |
| 01/29/2008 | US7323449 1-(2-(Hydroxymethyl)-5-thiolanyl)pyrrolo[2.3d]pyrimidine derivatives or their phosphates: 4-amino-7-(2-C-methyl-4-thio- beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine; hepatitis C virus |
| 01/29/2008 | US7323448 Antibacterial agents |
| 01/29/2008 | US7323442 Due to bacteria infections; administering lactoferrin |
| 01/29/2008 | US7323433 R-(-)-1-[2-(7-chlorobenzo[b]thiopen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole |
| 01/29/2008 | US7323316 Glycosyltransferase inhibitors |
| 01/29/2008 | US7323303 Modified β-lactamases and uses thereof |
| 01/29/2008 | US7323195 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/29/2008 | US7323180 Use of cross-protection to identify novel vaccine candidates for infectious agents |
| 01/29/2008 | US7323179 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
| 01/29/2008 | US7323177 delivery vectors for antigen producing genes (heterologous gene sequences or fragments thereof) used to generate immune responses in commercial pigs; recombinant porcine adenovirus capable of expressing DNA of interest |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
| 01/29/2008 | US7323118 Composition of hypochlorous acid and its applications |
| 01/29/2008 | CA2398485C Azalide antibiotic compositions |
| 01/29/2008 | CA2264735C Neisseria meningitidis serogroup b glycoconjugates and methods of using the same |
| 01/29/2008 | CA2263972C 6-o-substituted ketolides having antibacterial activity |
| 01/29/2008 | CA2142998C N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
| 01/29/2008 | CA2140928C Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/27/2008 | CA2594270A1 Antimicrobial hand wash |
| 01/24/2008 | WO2008011406A2 Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
| 01/24/2008 | WO2008011337A1 Hcv inhibitors |
| 01/24/2008 | WO2008011081A2 Wsx-1/p28 as a target for anti-inflammatory responses |
| 01/24/2008 | WO2008010953A2 Pyridinone diketo acids: inhibitors of hiv replication in combination therapy |
| 01/24/2008 | WO2008010921A2 Modulators of pharmacokinetic properties of therapeutics |
| 01/24/2008 | WO2008010776A1 Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection |
| 01/24/2008 | WO2008010478A1 Flagellin mutant vaccine |
| 01/24/2008 | WO2008010403A1 Method for preventing coloration of catechins and dentifrice composition |
| 01/24/2008 | WO2008010098A2 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 01/24/2008 | WO2008010010A1 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 01/24/2008 | WO2008009894A2 Use of imino sugars in immunotherapy |
| 01/24/2008 | WO2008009700A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 01/24/2008 | WO2008009650A2 Vaccines for malaria |
| 01/24/2008 | WO2008009613A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/24/2008 | WO2008009545A1 Anti-nkg2a antibodies and uses thereof |
| 01/24/2008 | WO2008009215A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 01/24/2008 | WO2008009209A1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases |
| 01/24/2008 | WO2008009138A1 Chlorogenic acid derivatives and their use as anti-fungal agents |
| 01/24/2008 | WO2008009122A1 Acrylamide derivatives as fab i inhibitors |
| 01/24/2008 | WO2008009078A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| 01/24/2008 | WO2008009077A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
| 01/24/2008 | WO2007140254A3 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 01/24/2008 | WO2007124733A3 Use of substituted glycerin derivatives for producing a pharmaceutical preparation |
| 01/24/2008 | WO2007103322A3 Compositions that include hemagglutinin, methods of making and methods of use thereof |
| 01/24/2008 | US20080022422 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/24/2008 | US20080021211 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 01/24/2008 | US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/24/2008 | US20080021110 Producing (-)-gossypol acetic acid co-crystals from (-)-gossypol acetone co-crystals, by substituting acetone in (-)-gossypol acetone co-crystals with acetic acid; use of gossypol acetic acid co-crystals and (-)-gossypol acetic acid co-crystals for inducing and for sensitizing cells to apoptosis |
| 01/24/2008 | US20080021106 Cellular uptake of bioactive agents |
| 01/24/2008 | US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders |
| 01/24/2008 | US20080021071 3-{4-(Pyridin-3-Yl) Phenyl}-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents |
| 01/24/2008 | US20080021059 Antibacterial Agents |
| 01/24/2008 | US20080021047 C-Purine Nucleoside Analogs As Inhibitors Of Rna-Dependent Rna Viral Polymerase |
| 01/24/2008 | US20080021039 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-[4-(4-methylpiperazin-1-yl-sulfonyl)-phenyl]-3H-imidazo-[4,5-b]pyridine,; acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, organ transplantation and transplant rejection, head trauma, acute lung injury |
| 01/24/2008 | US20080021037 Isethionate salt of a selective cdk4 inhibitor |
| 01/24/2008 | US20080021012 3-[4-{6-Substituted Alkanoyl Pyridin-3-Yl}-3-Phenyl]-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents |
| 01/24/2008 | US20080021011 Therapeutic compounds |
| 01/24/2008 | US20080020989 Cancer, hepatitis C virus infection, mmunomodulators; Acetic acid 2-acetoxymethyl-5-(5-formylamino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-isopropoxycarbonyloxy-tetrahydro-furan-3-yl ester |
| 01/24/2008 | US20080020985 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 01/24/2008 | US20080020976 Fragment of the C-terminal of dermcidin protein; protective skin treatment |
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020060 Process for treating rhinitis |